The members of Ranbaxy Laboratories have approved to issue 46,258,063 fully paid equity shares of Rs 5 each and 23,834,333 warrants - each warrant exercisable between six months to eighteen months from the date of allotment at the option of the warrant holder for one fully paid equity share of the company of Rs 5 each at a price of Rs 737 on preferential basis to Daiichi Sankyo Company, Japan.
This was approved at the extraordinary general meeting held on 15 July 2008.
No comments:
Post a Comment